Patent · US Active

Pro-coagulant compounds and methods of use thereof

US9486507B2 · kind B2 · utility

3Cited by
82References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 9, 2012
Grant dateNov 8, 2016
Priority date
Expiry dateJun 9, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides pro-coagulant compounds (e.g., pro-coagulant peptides or peptide derivatives) and methods of using and making those compounds. The present disclosure further provides conjugates between a pro-coagulant compound of the present disclosure (e.g., pro-coagulant peptide or peptide derivative) and a polypeptide selected from FIX, FVIIa, FVIII, and platelet targeting moieties (e.g., PDG-13), wherein the compound is linked to the polypeptide optionally via a linker. The compounds and conjugates of the present disclosure are useful for the treatment of coagulation disorders, such as hemophilia A and hemophilia B. The present disclosure further provides methods of using and making the conjugates.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.